Metformin and the risk of malignant tumors of digestive system: a mendelian randomization study
Abstract Background Observational studies suggest that metformin may reduce the risk of malignant tumors of the digestive system (MTDS), but these findings are often confounded by bias and unmeasured variables. Recent meta-analyses have questioned these associations, emphasizing the need for robust...
Saved in:
Main Authors: | Ping Liu, Junqi Xiao, Jinghuang Xiao, Jumei Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13098-024-01573-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trace elements selenium and potassium are protective factors for cutaneous malignant melanoma: A Mendelian randomization study
by: Chen-Yu Li, et al.
Published: (2025-02-01) -
Causal Association Between Skin Microbiota and Malignant Melanoma: Genetic Insights From Mendelian Randomization
by: Li X, et al.
Published: (2025-01-01) -
Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study
by: DengZhuo Chen, et al.
Published: (2025-01-01) -
Role of T cell metabolism in brain tumor development: a genetic and metabolic approach
by: Bo Yang, et al.
Published: (2025-01-01) -
Lipid Profiles, Telomere Length, and the Risk of Malignant Tumors: A Mendelian Randomization and Mediation Analysis
by: Shupeng Liu, et al.
Published: (2024-12-01)